These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31077859)

  • 1. High prevalence of B2-ST131 clonal group among extended-spectrum β-lactamase-producing Escherichia coli isolated from bloodstream infections in Quito, Ecuador.
    Zurita J; Solís MB; Ortega-Paredes D; Barba P; Paz Y Miño A; Sevillano G
    J Glob Antimicrob Resist; 2019 Dec; 19():216-221. PubMed ID: 31077859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.
    Merino I; Shaw E; Horcajada JP; Cercenado E; Mirelis B; Pallarés MA; Gómez J; Xercavins M; Martínez-Martínez L; De Cueto M; Cantón R; Ruiz-Garbajosa P;
    J Antimicrob Chemother; 2016 Aug; 71(8):2125-30. PubMed ID: 27494832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
    Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
    PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance dissemination by extended-spectrum β-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil.
    Gonçalves LF; de Oliveira Martins-Júnior P; de Melo ABF; da Silva RCRM; de Paulo Martins V; Pitondo-Silva A; de Campos TA
    J Glob Antimicrob Resist; 2016 Sep; 6():1-4. PubMed ID: 27530830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Characteristics of Sequence Type 131
    Park JY; Yun KW; Choi EH; Lee HJ
    Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
    Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.
    Karfunkel D; Carmeli Y; Chmelnitsky I; Kotlovsky T; Navon-Venezia S
    Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):513-21. PubMed ID: 23117265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of CTX-M extended-spectrum beta-lactamases and sequence type 131 in Korean blood, urine, and rectal Escherichia coli isolates.
    Graham SE; Zhang L; Ali I; Cho YK; Ismail MD; Carlson HA; Foxman B
    Infect Genet Evol; 2016 Jul; 41():292-295. PubMed ID: 27101781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany.
    Pietsch M; Eller C; Wendt C; Holfelder M; Falgenhauer L; Fruth A; Grössl T; Leistner R; Valenza G; Werner G; Pfeifer Y;
    Vet Microbiol; 2017 Feb; 200():130-137. PubMed ID: 26654217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ready-to-eat street food: a potential source for dissemination of multidrug-resistant Escherichia coli epidemic clones in Quito, Ecuador.
    Zurita J; Yánez F; Sevillano G; Ortega-Paredes D; Paz Y Miño A
    Lett Appl Microbiol; 2020 Mar; 70(3):203-209. PubMed ID: 31837237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.
    Namaei MH; Yousefi M; Ziaee M; Salehabadi A; Ghannadkafi M; Amini E; Askari P
    Microb Drug Resist; 2017 Oct; 23(7):879-884. PubMed ID: 28437226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
    Hansen F; Olsen SS; Heltberg O; Justesen US; Fuglsang-Damgaard D; Knudsen JD; Hammerum AM
    Microb Drug Resist; 2014 Aug; 20(4):316-24. PubMed ID: 24517383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
    Matsumura Y; Yamamoto M; Nagao M; Hotta G; Matsushima A; Ito Y; Takakura S; Ichiyama S;
    J Antimicrob Chemother; 2012 Nov; 67(11):2612-20. PubMed ID: 22843833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominance of CTX-M-type extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China.
    Xia S; Fan X; Huang Z; Xia L; Xiao M; Chen R; Xu Y; Zhuo C
    PLoS One; 2014; 9(7):e100707. PubMed ID: 24983621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Prevalence of Escherichia coli-Producing CTX-M-15 Extended-Spectrum Beta-Lactamases in Poultry and Human Clinical Isolates in Romania.
    Maciuca IE; Williams NJ; Tuchilus C; Dorneanu O; Guguianu E; Carp-Carare C; Rimbu C; Timofte D
    Microb Drug Resist; 2015 Dec; 21(6):651-62. PubMed ID: 25734920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China.
    Wang S; Zhao SY; Xiao SZ; Gu FF; Liu QZ; Tang J; Guo XK; Ni YX; Han LZ
    PLoS One; 2016; 11(1):e0147740. PubMed ID: 26824702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes.
    Brisse S; Diancourt L; Laouénan C; Vigan M; Caro V; Arlet G; Drieux L; Leflon-Guibout V; Mentré F; Jarlier V; Nicolas-Chanoine MH;
    J Clin Microbiol; 2012 Sep; 50(9):2974-81. PubMed ID: 22760036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.